Details for New Drug Application (NDA): 215658
✉ Email this page to a colleague
The generic ingredient in GANIRELIX ACETATE is ganirelix acetate. There are four drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the ganirelix acetate profile page.
Summary for 215658
Tradename: | GANIRELIX ACETATE |
Applicant: | Gland Pharma Ltd |
Ingredient: | ganirelix acetate |
Patents: | 0 |
Pharmacology for NDA: 215658
Mechanism of Action | Gonadotropin Releasing Hormone Receptor Antagonists |
Physiological Effect | Decreased GnRH Secretion |
Suppliers and Packaging for NDA: 215658
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
GANIRELIX ACETATE | ganirelix acetate | INJECTABLE;INJECTION | 215658 | ANDA | Fresenius Kabi USA, LLC | 65219-028 | 65219-028-05 | 1 SYRINGE, GLASS in 1 CARTON (65219-028-05) / 1 mL in 1 SYRINGE, GLASS |
GANIRELIX ACETATE | ganirelix acetate | INJECTABLE;INJECTION | 215658 | ANDA | Gland Pharma Limited | 68083-472 | 68083-472-01 | 1 BLISTER PACK in 1 CARTON (68083-472-01) / 1 SYRINGE, GLASS in 1 BLISTER PACK / 1 mL in 1 SYRINGE, GLASS |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 250MCG/0.5ML | ||||
Approval Date: | Feb 28, 2023 | TE: | AP | RLD: | No |
Complete Access Available with Subscription